Colchicine for the secondary prevention of cardiovascular events
This review is based on its protocol, which is available via DOI 10.1002/14651858.CD014808, and a previous review, which is available via DOI 10.1002/14651858.CD011047.pub2.
Authors
- Marc A. Beer (ORCID: https://orcid.org/0000-0003-1374-0705)
- Ramin Ebrahimi (ORCID: https://orcid.org/0000-0003-3728-1339)
- Julian Hirt (ORCID: https://orcid.org/0000-0001-6589-3936)
- Matthias Briel (ORCID: https://orcid.org/0000-0002-2070-5230)
- Perrine Janiaud (ORCID: https://orcid.org/0000-0001-7684-8014)
- Fahim Ebrahimi (ORCID: https://orcid.org/0000-0001-5862-966X)
- Lars G. Hemkens (ORCID: https://orcid.org/0000-0002-3444-1432)
- Hannah Ewald (ORCID: https://orcid.org/0000-0002-5081-1093)
- Christof Schönenberger
Institutions
- University of Bern (CH)
- Bern University of Applied Sciences (CH)
- University of Basel (CH)
- Universitätsmedizin Greifswald (DE)
- University Hospital of Basel (CH)
- Karolinska Institutet (SE)
- OST - Ostschweizer Fachhochschule (CH)
- Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE)
- University of Applied Sciences St. Gallen (CH)
- Martin Luther University Halle-Wittenberg (DE)
- Praxis (EE)
- Stanford University (US)
Publication Details
- Journal
- Cochrane Database of Systematic Reviews
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1002/14651858.cd014808.pub2
- Citations
- 1
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.81